Currentlyi Mab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Currentlyi Mab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Currentlyi Mab Today - Breaking & Trending Today

I-Mab Partner MorphoSys Announces New License Agreements for Felzartamab and TJ210

Published: June 15, 2022

/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...

Source: prnewswire.com

Related Topics:

United StatesHong KongSan DiegoSouth KoreaMacau GeneralEmilie WuAndrew ZhuGigi FengRichard YehPrnewswire The Company NasdaqPiacente Group IncExchange CommissionHuman Immunology Biosciences IncHuman Immunology BiosciencesMonograph CapitalCurrentlyi MabGreater ChinaSecurities Litigation Reform ActPiacente GroupI MabHealth Care Amp Hospitals Medical Pharmaceuticals Pharmaceuticals Biotechnology